ATAC - Endometrial Sub-Protocol
To compare the difference between the ARIMIDEX group and the tamoxifen group in the incidence of abnormal endometrial histological findings arising after treatment has commenced.
Breast Cancer
DRUG: Anastrozole (Arimidex)|DRUG: Tamoxifen (Nolvadex)|DRUG: Nolvadex placebo|DRUG: Arimidex placebo
Withdrawl|Death
To compare the difference between the ARIMIDEX group and the tamoxifen group in the incidence of abnormal endometrial histological findings arising after treatment has commenced.